The U.S. government does not have an explicit budget line for hepatitis elimination. However, it benefits from U.S.

The Trump administration is said to be considering closing the CDC's Division of HIV Prevention (DHP), a plan that leaves ...

Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...

HHS is considering major cuts to federal HIV prevention funding as part of a CDC reorganization, potentially affecting programs like PrEP. Experts warn the move could hinder efforts to combat the ...

Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January 2025, Atea is initiating a global Phase 3 program and expects patient ...

Understanding liver fibrosis progression through machine learning provides valuable insights into disease mechanisms, ...

Hepatitis B virus infection remains one of the leading causes of liver disease, including cirrhosis and hepatocellular carcinoma.

Two dozen people were sickened in the Netherlands after eating blueberries contaminated with hepatitis A. The National ...

Chronic hepatitis B virus (HBV) infection continues to pose a major global health threat. The virus evades immune responses and antiviral therapies due to the persistence of covalently closed circular ...

Hepatitis B virus (HBV) infection remains an urgent global health concern, affecting hundreds of millions of people and significantly heightening the risk ...

Hepatitis B virus (HBV) is the leading cause of cirrhosis, hepatocellular carcinoma, and liver-related death globally.1,2 The highest prevalence is found in low-income and middle-income countries ...

Officials and the media team in a group photograph Consultant Gastroenterologist, University of Ghana Medical Centre, Dr. Amoako Duah, has reiterated that viral hepatitis remains a major public health ...